Latest Genomics News

For a long time, cardiology relied on a “one-size-fits-all” approach to medication. If two patients had high blood pressure, they were often given the same drug at the same starting dose. However, we’ve all seen cases where a medication works wonders for one person but causes debilitating side effects or shows no results for another.

For millions of people worldwide, statins are a cornerstone of cardiovascular health. These cholesterol-lowering medications have saved countless lives by reducing the risk of heart attack and stroke. However, anyone who has spent time in a cardiology waiting room knows that statins don’t affect everyone the same way. While one person might see their LDL

For decades, the field of cardiology focused on treating the symptoms of heart disease through a generalized lens. If you had high blood pressure or irregular cholesterol levels, you were likely given a “standard” prescription based on what worked for the average person. However, as medicine enters the 21st century, we are moving away from

For decades, cardiology followed a relatively standard protocol: if a patient had high blood pressure or high cholesterol, they were prescribed the most common medication at a standard dose. If that didn’t work, or if side effects occurred, the doctor would try the next option. This “trial and error” approach is rapidly becoming a thing